Esfam Biotech Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$25M
- Investors
-
2
Esfam Biotech General Information
Description
Operator of a biotech company intended to target human and animal diseases in the areas of oncology and viral infections. The company focuses on developing anti-cancer treatments against other common poorly responsive cancers, such as pancreatic, ovarian, kidney, lung, colorectal, melanoma, and breast cancer, enabling patients by conducting molecular research on significant diseases affecting global populations today.
Contact Information
Website
www.mlsbio.comCorporate Office
- Level 10, 440 Collins Street
- Melbourne, Victoria 3000
- Australia
Corporate Office
- Level 10, 440 Collins Street
- Melbourne, Victoria 3000
- Australia
Esfam Biotech Timeline
Esfam Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 10-Oct-2025 | $25M | Completed | Generating Revenue | ||
| 1. Angel (individual) | 10-Oct-2025 | Completed | Generating Revenue |
Esfam Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Esfam Biotech Patents
Esfam Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026905173-A0 | Method of treatment | Pending | 01-Jun-2026 | ||
| AU-2025902131-A0 | Method of treatment | Pending | 30-May-2025 | ||
| AU-2024901633-A0 | Method of treatment | Pending | 31-May-2024 | ||
| AU-2020903002-A0 | Methods of prophylaxis and treatment of corona virus | Pending | 21-Aug-2020 | ||
| US-12215112-B2 | Cd151 inhibitors | Active | 27-Jul-2020 | C07D487/04 |
Esfam Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Esfam Biotech Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Melbourne Angels | Angel Group | |||
| Perth Angels | Angel Group |
Esfam Biotech FAQs
-
When was Esfam Biotech founded?
Esfam Biotech was founded in 2015.
-
Where is Esfam Biotech headquartered?
Esfam Biotech is headquartered in Melbourne, Australia.
-
What is the size of Esfam Biotech?
Esfam Biotech has 6 total employees.
-
What industry is Esfam Biotech in?
Esfam Biotech’s primary industry is Biotechnology.
-
Is Esfam Biotech a private or public company?
Esfam Biotech is a Private company.
-
What is Esfam Biotech’s current revenue?
The current revenue for Esfam Biotech is .
-
How much funding has Esfam Biotech raised over time?
Esfam Biotech has raised $25.7M.
-
Who are Esfam Biotech’s investors?
Melbourne Angels and Perth Angels have invested in Esfam Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
